|
π’
|
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
15 auth.
Yoko S Derose,
Guoying Wang,
Yi-Chun Lin,
P. Bernard,
S. Buys,
Mark T. W. Ebbert,
R. Factor,
C. Matsen,
B. Milash,
Edward W. Nelson,
...
L. Neumayer,
R. Randall,
I. Stijleman,
B. Welm,
A. Welm
|
9 |
2011 |
9
π’
|
|
π
|
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.
26 auth.
Hsing-Chen Tsai,
Huili Li,
L. van Neste,
Yi Cai,
C. Robert,
F. Rassool,
James Shin,
Kirsten Harbom,
R. Beaty,
E. Pappou,
James C. Harris,
R. Yen,
N. Ahuja,
M. Brock,
V. Stearns,
...
D. Feller-Kopman,
L. Yarmus,
Yi-Chun Lin,
A. Welm,
J. Issa,
I. Minn,
W. Matsui,
Yoon-Young Jang,
S. Sharkis,
S. Baylin,
C. Zahnow
|
9 |
2012 |
9
π
|
|
π
|
Protective autophagy elicited by RAFβMEKβERK inhibition suggests a treatment strategy for RAS-driven cancers
23 auth.
Conan G Kinsey,
S. Camolotto,
A. Boespflug,
Katrin P. Guillen,
M. Foth,
A. Truong,
Sophia Schuman,
J. Shea,
M. Seipp,
J. Yap,
...
L. Burrell,
D. Lum,
J. Whisenant,
G. Gilcrease,
Courtney C. Cavalieri,
Kaitrin M. Rehbein,
Stephanie L. Cutler,
Kajsa E Affolter,
A. Welm,
B. Welm,
C. Scaife,
E. Snyder,
M. McMahon
|
8 |
2019 |
8
π
|
|
π
|
Plasma exosome microRNAs are indicative of breast cancer
10 auth.
Bethany N. Hannafon,
Yvonne D. Trigoso,
Cameron L. Calloway,
Y. D. Zhao,
D. Lum,
A. Welm,
...
Z. Zhao,
K. Blick,
W. Dooley,
W. Ding
|
8 |
2016 |
8
π
|
|
π
|
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
30 auth.
A. Bruna,
O. Rueda,
W. Greenwood,
A. Batra,
M. Callari,
R. Batra,
Katherine L. Pogrebniak,
JosΓ© L. Sandoval,
J. Cassidy,
Ana Tufegdzic-Vidakovic,
S. Sammut,
Linda Jones,
E. Provenzano,
R. Baird,
P. Eirew,
...
J. Hadfield,
M. Eldridge,
Anne McLaren-Douglas,
Andrew S. Barthorpe,
H. Lightfoot,
M. OβConnor,
J. Gray,
J. CortΓ©s,
J. Baselga,
E. Marangoni,
A. Welm,
S. Aparicio,
V. Serra,
M. Garnett,
C. Caldas
|
8 |
2016 |
8
π
|
|
π’
|
The lingering mysteries of metastatic recurrence in breast cancer
A. Riggio,
K. Varley,
A. Welm
|
8 |
2020 |
8
π’
|
|
π¬
|
Understanding the Bone in Cancer Metastasis
Jaime Fornetti,
A. Welm,
S. Stewart
|
8 |
2018 |
8
π¬
|
|
π
|
C/EBPΞ± Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4
7 auth.
Hongmei Wang,
P. Iakova,
M. Wilde,
A. Welm,
T. Goode,
W. Roesler,
...
N. Timchenko
|
8 |
2001 |
8
π
|
|
π¬
|
RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1*
N. Timchenko,
Z. Cai,
A. Welm,
S. Reddy,
T. Ashizawa,
L. Timchenko
|
8 |
2001 |
8
π¬
|
|
π
|
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
13 auth.
D. Micalizzi,
K. Christensen,
P. Jedlicka,
R. Coletta,
R. Coletta,
A. Baron,
J. Harrell,
K. Horwitz,
D. D. Billheimer,
K. Heichman,
...
A. Welm,
W. Schiemann,
H. Ford
|
7 |
2009 |
7
π
|
|
π
|
A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis
9 auth.
Q. Feng,
Chengliang Zhang,
D. Lum,
J. Druso,
Bryant S. Blank,
K. Wilson,
...
A. Welm,
M. Antonyak,
R. Cerione
|
7 |
2017 |
7
π
|
|
π
|
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
32 auth.
L. Dobrolecki,
S. Airhart,
D. AlfeΜrez,
S. Aparicio,
F. Behbod,
M. Bentires-Alj,
C. Brisken,
C. Bult,
Shirong Cai,
R. Clarke,
Heidi Dowst,
M. Ellis,
E. GonzΓ‘lez-SuΓ‘rez,
R. Iggo,
P. Kabos,
...
Shunqiang Li,
G. Lindeman,
E. Marangoni,
Aaron M. McCoy,
F. Meric-Bernstam,
H. Piwnica-Worms,
M. Poupon,
J. Reis-Filho,
Carol A. Sartorius,
Valentina Scabia,
George Sflomos,
Y. Tu,
F. Vaillant,
J. Visvader,
A. Welm,
M. Wicha,
M. Lewis
|
7 |
2016 |
7
π
|
